Hozumi M
Saitama Cancer Center Research Institute, Japan.
Anticancer Res. 1994 May-Jun;14(3A):1177-92.
It has been shown recently that various myeloid leukemia cells can be induced by numerous compounds to differentiate terminally into non-growing mature cells. Furthermore, some of these compounds have been found to be clinically useful for the therapy of certain types of myeloid leukemia. To improve this new method of differentiation therapy of leukemia, we have studied on basic issues of such differentiation therapy including 1) development of more effective new inducers of differentiation of leukemia cells, 2) isolation and characterization of cytokines regulating growth and differentiation of leukemia cells, and 3) rationale for chemo-differentiation therapy of leukemia which is a combination chemotherapy of leukemia with differentiation inducers and cytotoxic anticancer drugs. In this article, recent results of our studies on these basic issues on differentiation therapy of leukemia are reviewed.
最近已表明,多种化合物可诱导各种髓系白血病细胞终末分化为不再生长的成熟细胞。此外,已发现其中一些化合物在临床上可用于治疗某些类型的髓系白血病。为改进这种白血病分化疗法的新方法,我们研究了这种分化疗法的一些基本问题,包括:1)开发更有效的白血病细胞分化新诱导剂;2)分离和鉴定调节白血病细胞生长和分化的细胞因子;3)白血病化学分化疗法的基本原理,即白血病与分化诱导剂和细胞毒性抗癌药物联合化疗。本文综述了我们对白血病分化疗法这些基本问题的最新研究结果。